Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Pol Merkur Lekarski ; 35(206): 111-8, 2013 Aug.
Article in Polish | MEDLINE | ID: mdl-24052992

ABSTRACT

The most common tumor of the pancreas is cancer, which constitutes 85% of all pancreatic neoplasms. Cystic pancreatic tumors comprise 10% of malignancies. No more than 5% of pancreatic tumors are rare solid tumors as: neuroendocrine tumors, gastrointestinal stromal tumors, solid pseudopapillary tumors, pecomas, lymphomas, granulocytic sarcomas, schwannomas, lipomas, liposarcomas and metastases to pancreas. Nowadays, these tumors are diagnosed more commonly due to the developement and accessibility of the diagnostic imaging techniques. Moreover, the treatment and management of rare solid pancreatic tumors often differs from the management in pancreatic cancer what makes the differential diagnosis difficult and responsible challenge. The main purpose of this article is to present an actual data of epidemiology, clinical presentation, management and treatment of rare solid pancreatic tumors according to recent literature and self experience.


Subject(s)
Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/therapy , Diagnosis, Differential , Humans , Lipoma/diagnosis , Lipoma/pathology , Lipoma/therapy , Liposarcoma/diagnosis , Liposarcoma/pathology , Liposarcoma/secondary , Liposarcoma/therapy , Lymphoma/diagnosis , Lymphoma/pathology , Lymphoma/therapy , Neurilemmoma/diagnosis , Neurilemmoma/pathology , Neurilemmoma/secondary , Neurilemmoma/therapy , Pancreatic Neoplasms/pathology , Pancreatic Neoplasms/secondary , Rare Diseases , Sarcoma/diagnosis , Sarcoma/pathology , Sarcoma/secondary , Sarcoma/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...